Tomoda, Akemi, Joudoi, Takako, Rabab, El-Mezayen et al. · Psychiatry research · 2005 · DOI
This study examined immune system chemicals called cytokines in people with ME/CFS compared to healthy volunteers. Researchers took blood cells from both groups and stimulated them in the laboratory to see how they would respond. They found that ME/CFS patients produced lower levels of certain immune chemicals, particularly one called TGF-beta1, which might play a role in the inflammation seen in ME/CFS.
Understanding immune system dysfunction in ME/CFS is crucial for developing effective treatments. This study provides evidence that cytokine imbalances are measurable biological abnormalities in ME/CFS, strengthening the case that the illness has a biological basis rather than a purely psychological one. The identification of TGF-beta1 as potentially therapeutic opens a new avenue for future drug development.
This study does not prove that low TGF-beta1 causes ME/CFS, only that it is associated with the condition. Laboratory findings from stimulated blood cells may not reflect what actually happens in patients' bodies during daily life. Additionally, the small sample size means these findings need replication in larger, more diverse populations before drawing firm conclusions about treatment approaches.